Sentence examples for setting defined as from inspiring English sources

This provided the trainees with adequate knowledge of when HH is required in a clinical setting, defined as an opportunity or indication, what appropriate HH consists of and how to complete an assessment form.

In the case of an emergency setting, defined as non-scheduled endoscopic examination of the colon for acute colonic conditions such as lower gastrointestinal bleeding, patients would undergo the aforementioned protocol of bowel preparation if possible.

Overall, 53.4% of the respondents reported to work in rural settings (defined as serving a population with fewer than 20,000 inhabitants), and 46.6% reported to work in an urban setting (defined as serving a population with more than 20,000 inhabitants.

Let X be a finite set defined as (X={1,2,3,4}).

QLQ-C30 set: defined as all ITT patients having an assessable QLQ-C30 (<50% of missing responses) at baseline, FACIT-CCSQ set: defined as all ITT patients having an assessable FACIT-CCSQ (<50% of missing responses) at baseline.

Efficacy outcomes were assessed for the full analysis set, defined as all patients who were randomized and took at least one dose of study drug.

Two HRQoL sets were considered: QLQ-C30 set: defined as all ITT patients having an assessable QLQ-C30 (<50% of missing responses) at baseline, FACIT-CCSQ set: defined as all ITT patients having an assessable FACIT-CCSQ (<50% of missing responses) at baseline.

The minimal intervention set, defined as a minimal set of important nodes whose simultaneous manipulation satisfies a user-defined goal (e.g. permanent deactivation of the output) [ 10, 46], identifies minimum failure modes for signaling networks and regulatory networks.

As we would expect the patients to get better, we studied the positive event "recovery", for this example data set defined as zero or one pain day reported in two consecutive weeks [ 18].

All analyses were based on the full analysis set, defined as patients who were randomized and took at least one dose of study drug, but excluding patients from one site (n = 15) where there were violations of good clinical practice.

Safety parameters were evaluated in the safety analysis set, defined as all patients, except those who did not receive any study drug during the treatment phase or who did not have any safety data during the treatment phase.